SYNGENE Syngene International Ltd Company Mergers Announcement 2023 - Acquisition of Biologics Manufacturing Facility Syngene International has concluded the acquisition of a biologics manufacturing facility from Stelis Biopharma for a revised gross value of Rs 617 crores..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Syngene International Ltd